Acute Lymphoblastic Leukemia: Challenges in MRD Testing
2 Bekeken
• 08/04/23
0
0
insluiten
administrator
abonnees
Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties